Back
Crinetics Pharmaceuticals 10K Form
Buy
68
CRNX
Crinetics Pharmaceuticals
Last Price:
59.10
Seasonality Move:
10.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRNX News And Ratings
See the #1 stock for the next 7 days that we like better than CRNX
CRNX Financial Statistics
Sales & Book Value
| Annual Sales: | $4.01M |
|---|---|
| Cash Flow: | $-46.57M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.47 |
| Price / Book: | 5.57 |
Profitability
| EPS (TTM): | -3.78000 |
|---|---|
| Net Income (TTM): | $-258.54M |
| Gross Margin: | -- |
| Return on Equity: | -42.43% |
| Return on Assets: | -37.11% |
Crinetics Pharmaceuticals Earnings Forecast
Key Crinetics Pharmaceuticals Financial Ratios
- The Research & Development expenses have been 4,199.53% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of CRNX is -5,345.85% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 1 years.
Crinetics Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRNX |
| CUSIP: | 22663K |
| Website: | crinetics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 16.09 |
| Quick Ratio: | 15.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRNX Technical Analysis vs Fundamental Analysis
Buy
68
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a Buy
The current Crinetics Pharmaceuticals [CRNX] share price is $57.81. The Score for CRNX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.